Step 1 topics → Endocrine → Thyroiditis (de Quervain, Silent, Hashimoto, Riedel)

Thyroiditis (de Quervain, Silent, Hashimoto, Riedel)

USMLE Step 1 trap: Expects high RAIU in de Quervain thyroiditis hyperthyroid phase rather than characteristically low uptake. De Quervain thyroiditis shows low RAIU during the hyperthyroid phase because hormone is released from destroyed follicles, not synthesized de novo.

Thyroiditis covers four distinct conditions that USMLE Step 1 loves to pit against each other: de Quervain (subacute granulomatous), silent/postpartum (painless lymphocytic), Hashimoto (chronic autoimmune), and Riedel (fibrosclerosing). The exam tests these at multiple levels — sometimes pure recall (which antibodies define Hashimoto?), sometimes application (why is RAIU low if the patient is hyperthyroid?), and sometimes passage interpretation where you have to extract the key distinguishing feature buried in a clinical vignette and map it to the correct diagnosis. The unifying trap is that three of these can cause a transient hyperthyroid phase, so if you're only pattern-matching on thyroid function tests, you'll get burned.

The biggest conceptual pitfall is conflating the mechanism of hyperthyroidism in thyroiditis with Graves disease. In Graves, TSI drives active hormone synthesis — so RAIU is high. In any form of thyroiditis, the gland is being destroyed, releasing preformed hormone passively — so RAIU is low. This distinction is the single most tested diagnostic pearl across this entire topic on USMLE Step 1, and it applies to de Quervain, silent, and postpartum thyroiditis equally. Students who memorize 'hyperthyroid = high RAIU' will miss every question that hinges on this mechanism.

The other recurrent confusion is between the four types themselves. De Quervain is painful and post-viral; silent/postpartum is painless and autoimmune — these are not the same disease with different severity. Hashimoto gets its antibodies mixed up with Graves constantly. And Riedel is the outlier that most students never fully learn: it's an IgG4-related disease, it mimics anaplastic carcinoma on exam, and it responds to steroids — knowing those three facts is essentially everything Step 1 wants from you on Riedel.

From real student decks
62%have cards covering this topic
51%have mature cards
1median lapses in 14 days

Common misconceptions

Common mistake
Wrong: The early hyperthyroid phase of de Quervain thyroiditis shows high RAIU like Graves disease.
Right: De Quervain thyroiditis shows low RAIU during the hyperthyroid phase because hormone is released from destroyed follicles, not synthesized de novo.
In de Quervain thyroiditis, the hyperthyroid phase results from physical destruction of follicles releasing stored T3 and T4 into circulation — the thyroid is not being stimulated to synthesize new hormone. Because iodine uptake is a marker of active synthesis, RAIU is actually suppressed (low) despite elevated thyroid hormone levels. High RAIU in hyperthyroidism specifically indicates a hyperfunctioning gland driven by TSH-receptor stimulation, as in Graves — this mechanism is completely absent in thyroiditis.
Common mistake
Wrong: Silent/postpartum thyroiditis is painful like de Quervain thyroiditis.
Right: Silent and postpartum thyroiditis are painless autoimmune thyroiditides, whereas de Quervain is painful and follows a viral upper respiratory infection.
De Quervain and silent/postpartum thyroiditis share a triphasic functional course but are mechanistically and clinically different diseases. De Quervain follows a viral upper respiratory infection, causes significant anterior neck pain and tenderness, and has a granulomatous histology — it is not autoimmune. Silent and postpartum thyroiditis are painless autoimmune conditions with anti-TPO antibodies and lymphocytic histology; the 'silent' label literally refers to the absence of the pain that defines de Quervain. Confusing them on a vignette usually comes down to missing (or misreading) the pain descriptor.
Common mistake
Wrong: Anti-TSH receptor antibodies (TSI) are the hallmark of Hashimoto thyroiditis.
Right: Hashimoto thyroiditis is characterized by anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies, not TSI.
TSI (thyroid-stimulating immunoglobulin) acts as a TSH-receptor agonist and is the hallmark of Graves disease — it drives hyperthyroidism by continuously stimulating the gland. Hashimoto thyroiditis is characterized instead by anti-thyroid peroxidase (anti-TPO, formerly called anti-microsomal) and anti-thyroglobulin antibodies, which are markers of autoimmune destruction, not stimulation. Anti-TPO is the more sensitive and clinically used antibody for Hashimoto; knowing this distinction protects you from swapping the antibodies between these two very different diseases.
Common mistake
Wrong: Hashimoto thyroiditis predisposes primarily to papillary thyroid carcinoma.
Right: Hashimoto thyroiditis is most strongly associated with primary thyroid lymphoma (B-cell NHL), not papillary carcinoma.
While Hashimoto thyroiditis does occur in the same gland as papillary thyroid carcinoma and the two can coexist, the malignancy most strongly associated with Hashimoto — and the one Step 1 specifically tests — is primary thyroid lymphoma, a B-cell NHL. The logic is mechanistic: the chronic lymphocytic infiltration of Hashimoto creates a microenvironment that predisposes to lymphoid malignant transformation. When a vignette shows rapid gland enlargement in a patient with known Hashimoto, think lymphoma first.
Common mistake
Gap: Misses that Riedel thyroiditis is IgG4-related and steroid-responsive, not a malignancy
Riedel thyroiditis is an IgG4-related fibrosclerosing disease that can mimic anaplastic thyroid carcinoma clinically but is treated with steroids and tamoxifen, not surgery.
Riedel thyroiditis is classified under IgG4-related disease, a systemic fibrosclerosing condition that can affect multiple organs (pancreas, salivary glands, retroperitoneum). In the thyroid it produces a rock-hard, woody, fixed gland that can compress the trachea and esophagus — this presentation mimics anaplastic thyroid carcinoma clinically and that's exactly how Step 1 tests it. The critical distinction is that Riedel responds to corticosteroids and tamoxifen, whereas anaplastic carcinoma does not; recognizing the IgG4-related context (or other organ involvement) in the vignette is your clue to avoid calling it cancer.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. De Quervain thyroiditis: know the trigger (viral URI), the clinical course (hyperthyroid → hypothyroid → euthyroid), the characteristic pain, and the granulomatous histology with giant cells.
  2. Silent and postpartum thyroiditis: contrast these with de Quervain — both are painless, both are autoimmune (anti-TPO positive), both follow the same triphasic functional course, but neither is triggered by infection and neither is painful.
  3. Hashimoto thyroiditis: identify the correct antibodies (anti-TPO and anti-thyroglobulin, not TSI), recognize the lymphocytic infiltrate with germinal centers and Hürthle cell change on histology, and know the associated malignancy risk.
  4. Riedel thyroiditis: recognize it as an IgG4-related fibrosclerosing disease, understand why it clinically mimics anaplastic thyroid carcinoma (hard, fixed, invasive-feeling neck mass), and know it is treated with steroids and tamoxifen — not surgery.
  5. Using radioactive iodine uptake (RAIU) to distinguish thyroiditis from Graves disease or toxic nodules: low RAIU in the setting of hyperthyroidism points to destructive thyroiditis, while high RAIU points to active hormone synthesis.

Can you avoid these mistakes?

A 35-year-old woman presents 6 weeks postpartum with palpitations, heat intolerance, and a TSH of 0.05. Her thyroid is nontender. RAIU is 2% (normal 10–30%). What is the diagnosis, and what finding on antibody testing would you expect?
A 45-year-old man presents with a painful, tender thyroid following a URI two weeks ago. Labs show elevated T4, suppressed TSH, and elevated ESR. RAIU is very low. A colleague suggests this is Graves disease. What single finding most definitively rules out Graves disease, and why?
A patient with longstanding Hashimoto thyroiditis presents with rapid, painless enlargement of her thyroid over four weeks. Fine-needle aspiration shows large lymphoid cells. What is the most likely diagnosis, and what antibody was likely positive years earlier at her Hashimoto diagnosis?
A 55-year-old woman presents with a hard, fixed, non-tender thyroid mass with dysphagia and hoarseness. Biopsy shows dense fibrosis with no malignant cells. Serum IgG4 is elevated. What is the diagnosis, how does it mimic a malignancy clinically, and what is the first-line treatment?

Related topics

Hypothalamic-Pituitary-Thyroid (HPT) Axis Hypothalamic-Pituitary-Adrenal (HPA) Axis Hypothalamic-Pituitary-Gonadal (HPG) Axis Hormone Signaling (Peptide vs Steroid)

See how your Anki deck covers this topic.

Upload your deck for a free audit →